Evenity (romosozumab) clears from your bloodstream within roughly two to three months after your final injection. The drug has an estimated half-life of about 12.8 days, meaning your body eliminates half of the remaining drug approximately every 13 days. After about five half-lives, or around 64 days, the amount left in your system is negligible.
How Your Body Processes Evenity
Evenity is a monoclonal antibody, which means it’s a large protein molecule rather than a traditional small-molecule drug. Your body breaks it down the same way it breaks down its own natural antibodies: enzymes gradually chop it into small protein fragments and amino acids that get recycled or excreted. This process doesn’t rely on your liver or kidneys in any significant way, which is why people with kidney disease or liver problems don’t need a dose adjustment.
After each monthly injection of 210 mg, the drug reaches its peak concentration in your blood within about 5 days, though this can range from 2 to 7 days depending on the person. From there, levels gradually decline over the following weeks. Because you receive a new dose every month, the drug maintains a therapeutic level throughout the 12-month treatment course. Once you stop, there’s no new dose coming in, and what remains follows that roughly 13-day half-life curve downward.
Why It’s Limited to 12 Months
Evenity works by blocking a protein called sclerostin, which normally puts the brakes on bone formation. When that brake is removed, your bone-building cells go into overdrive. But this surge in bone formation doesn’t last forever. The anabolic effect of Evenity wanes after 12 monthly doses, even if you were to keep taking it. Your body adapts to the drug’s presence, and the bone-building boost tapers off. That’s why treatment is capped at one year rather than continued indefinitely.
This doesn’t mean you’re done with osteoporosis treatment after 12 months. It means the specific bone-building phase is over.
What Happens After Your Last Dose
The bone density gains you made during 12 months of Evenity can start to decline once the drug leaves your system if you don’t follow up with another type of osteoporosis medication. Clinical guidelines recommend transitioning to an antiresorptive therapy, such as a bisphosphonate or denosumab, to lock in the new bone you’ve built. The American Association of Clinical Endocrinology specifically recommends following Evenity with a drug intended for long-term use to prevent bone density decline and preserve fracture protection.
This transition typically happens right after the 12-month Evenity course ends. There’s no waiting period required for the drug to clear before starting the next medication. The goal is continuity: Evenity builds the bone, and the follow-up drug keeps it from being reabsorbed.
Factors That Affect Clearance Time
Because Evenity is broken down through the same natural process your body uses for its own antibodies, the clearance timeline is relatively consistent across different people. Kidney function, including end-stage renal disease requiring dialysis, does not meaningfully change how long the drug stays in your system. Liver impairment hasn’t been formally studied, but since Evenity isn’t processed through liver metabolism, it’s not expected to matter.
Body weight can play a modest role. Larger individuals may clear monoclonal antibodies at slightly different rates than smaller individuals, but this doesn’t change the overall timeline dramatically. For most people, Evenity is effectively gone within about two months of the last injection, with any biological trace amounts disappearing shortly after that.
Drug in Your System vs. Effects on Your Bones
It’s worth separating two different questions: how long the drug molecule circulates in your blood, and how long its effects last. The drug itself clears in roughly two months. But the bone it helped build is real, physical bone tissue that remains in your skeleton. The structural changes to your bones don’t disappear when the drug does. What does change is the rate of bone turnover. Without follow-up treatment, your body gradually shifts back toward its previous balance of bone building and bone breakdown, which in someone with osteoporosis means a slow return toward net bone loss. That’s why the follow-up medication matters more than the exact clearance timeline of Evenity itself.